The importance of being able to compare: methodologies that result in the best decisions by Ana Clopés-Estela, Ana Ortega-Eslava

Connect to this object online.

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report by María Espinosa Bosch, Rocío Asensi Diez, Sara García Agudo, Ana Clopes Estela

Connect to this object online.

Real‐world treatment outcomes of immune checkpoint inhibitors used off‐label in oncology: A comprehensive cancer institution experience by Sandra Fontanals, Anna Esteve, Andrea González, Cristina Ibáñez, Ricard Mesía, Ana Clopés

Connect to this object online.

Survey of oncohematological pharmaceutical care situation in Spain by María José Martínez-Bautista, Irene Mangues-Bafalluy, Gerardo Cajaraville-Ordoñana, María Josep Carreras-Soler, Ana Clopés-Estela, Estela Moreno-Martínez

Connect to this object online.

Off-label use of oncology drugs: national survey results by Eva González-Haba Peña, María José Agustín Ferrández, Irene Mangues Bafalluy, Nicolás Alfredo López, María Dolores Fraga Fuentes, Roberto Marín Gil, María José Martínez Bautista, María José Martínez Bautista, María José Martínez Bautista, Ana Clopés Estela

Connect to this object online.

An international comparative analysis and roadmap to sustainable biosimilar markets by Khalid A. Alnaqbi, Agnès Bellanger, Alex Brill, Gilberto Castañeda-Hernández, Ana Clopés Estela, Olga Delgado Sánchez, Pilar García-Alfonso, Pius Gyger, Daniel Heinrich, Germain Hezard, Adriana Kakehasi, Cheryl Koehn, Olivier Mariotte, Francesco Mennini, Sonia Mayra Pérez-Tapia, Michele Pistollato, Rowan Saada, Tadanori Sasaki, George Tambassis, Marc Thill, Gustavo Werutsky, Tim Wilsdon, Steven Simoens

Connect to this object online.